| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BLNE | Series G Convertible Preferred Stock | Award | +1,764,706 | +30% | 7,641,488 | 24 Mar 2025 | Common Stock | 176,471 | $0.5100 | Direct | F1, F2, F3 | ||
| transaction | BLNE | Warrants to Purchase Common Stock | Award | +88,236 | +30% | 382,077 | 24 Mar 2025 | Common Stock | 88,236 | $0.6500 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Represents Series G Convertible Preferred Stock ("Series G") purchased by the Reporting Person pursuant to a Securities Purchase Agreement with the Issuer. The Series G are convertible into common stock at a conversion price of $5.10 per share. |
| F2 | The preferred stock is perpetual and therefore has no expiration date. |
| F3 | The Reporting Person paid a purchase price of $900,000 for the Series G and accompanying warrants. The Reporting Person had previously purchased $2,997,159 of Series G and accompanying warrants in transactions prior to March 24, 2025 as previously reported on prior Form 4s, for a total investment in the Series G and accompanying warrants of $3,897,159. Common Stock amounts give effect to the 1:10 reverse stock split effected on March 12, 2025. |
| F4 | Represents common stock purchase warrants having an exercise price of $6.50, which were purchased pursuant to the Securities Purchase Agreement referred to in footnote (1). |